Genmab — Maj 2018
-
Page or document not found | European Medicines Agency (EMA)
We are sorry, but the content you tried to access is unavailable at the link you used, which was either incorrect or out-of-date. To help you find what you are looking for, we have included some useful tips.
European Medicines Agency (EMA) (www.ema.europa.eu)
-
PK/PD modeling (pharmacokinetic/pharmacodynamic modeling) (alternatively abbreviated as PKPD[1] or PK-PD[2] modeling) is a technique that combines the two classical pharmacologic disciplines of pharmacokinetics and pharmacodynamics.[3] It integrates a pharmacokinetic and a pharmacodynamic model component into one set of mathematical expressions that allows the description of the time course of effect intensity in response to administration of a drug dose. PK/PD modeling is related to the field
-
blev du klogere?
-
De anonyme går fra et nettosalg på 54.000. Ned til et nettosalg på 13.000 i lukkeauktionen. Imponerende.
-
Det er svære tider i øjeblikket. Der er ikke andet at gøre end at holde på og håbe på en god nyhed eller to i den nærmeste fremtid.
-
Den eneste gode nyhed vi kan forvente i den kommende tid er MAIA. Hvor meget det vil give på kursen er ikke nemt at gætte.
-
Ofa i ms kommer i 2019
-
Ja slutningen af 18
men tak 
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind